Hospital-Acquired Infection Control Market by Product & Service (Sterilization, Cleaning & Disinfection Products, Protective Barriers, and Endoscope Reprocessing Products), Infection Type (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infections (UTI), and Others), and End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others)- Global Industry Analysis, Share, Growth, Regional Outlook And Forecasts, 2021-2027

Chapter 1.    Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.    Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.    Executive Summary

3.1.  Market Snapshot

Chapter 4.    Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.     Raw Material Procurement Analysis

4.3.2.     Sales and Distribution Channel Analysis

4.3.3.     Downstream Buyer Analysis

Chapter 5.    Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.     Market Drivers

5.1.2.     Market Restraints

5.1.3.     Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.     Bargaining power of suppliers

5.2.2.     Bargaining power of buyers

5.2.3.     Threat of substitute

5.2.4.     Threat of new entrants

5.2.5.     Degree of competition

Chapter 6.    Competitive Landscape

6.1.1.     Company Market Share/Positioning Analysis

6.1.2.     Key Strategies Adopted by Players

6.1.3.     Vendor Landscape

6.1.3.1.          List of Suppliers

6.1.3.2.          List of Buyers

Chapter 7.    Global Hospital-Acquired Infection Control Market, By Product & Service

7.1.  Hospital-Acquired Infection Control Market, by Product & Service, 2021-2027

7.1.1.     Sterilization

7.1.1.1.          Market Revenue and Forecast (2016-2027)

7.1.2.     Cleaning & Disinfection Products

7.1.2.1.          Market Revenue and Forecast (2016-2027)

7.1.3.     Protective Barriers

7.1.3.1.          Market Revenue and Forecast (2016-2027)

7.1.4.     Endoscope Reprocessing Products

7.1.4.1.          Market Revenue and Forecast (2016-2027)

Chapter 8.    Global Hospital-Acquired Infection Control Market, By Infection Type

8.1.  Hospital-Acquired Infection Control Market, by Infection Type, 2021-2027

8.1.1.     Product & Service

8.1.1.1.          Market Revenue and Forecast (2016-2027)

8.1.2.     Bloodstream Infections

8.1.2.1.          Market Revenue and Forecast (2016-2027)

8.1.3.     Surgical Site Infections

8.1.3.1.          Market Revenue and Forecast (2016-2027)

8.1.4.     Gastrointestinal Infections

8.1.4.1.          Market Revenue and Forecast (2016-2027)

8.1.5.     Urinary Tract Infections (UTI)

8.1.5.1.          Market Revenue and Forecast (2016-2027)

8.1.6.     Others

8.1.6.1.          Market Revenue and Forecast (2016-2027)

Chapter 9.    Global Hospital-Acquired Infection Control Market, By End User

9.1.  Hospital-Acquired Infection Control Market, by End User, 2021-2027

9.1.1.     Hospitals & Clinics

9.1.1.1.          Market Revenue and Forecast (2016-2027)

9.1.2.     Ambulatory Surgical Centers

9.1.2.1.          Market Revenue and Forecast (2016-2027)

9.1.3.     Others

9.1.3.1.          Market Revenue and Forecast (2016-2027)

Chapter 10.Global Hospital-Acquired Infection Control  Market, Regional Estimates and Trend Forecast

10.1.          North America

10.1.1.  Market Revenue and Forecast, by Product & Service (2016-2027)

10.1.2.  Market Revenue and Forecast, by Infection Type (2016-2027)

10.1.3.  Market Revenue and Forecast, by End User (2016-2027)

10.1.4.  U.S.

10.1.4.1.       Market Revenue and Forecast, by Product & Service (2016-2027)

10.1.4.2.       Market Revenue and Forecast, by Infection Type (2016-2027)

10.1.4.3.       Market Revenue and Forecast, by End User (2016-2027)

10.1.5.  Rest of North America

10.1.5.1.       Market Revenue and Forecast, by Product & Service (2016-2027)

10.1.5.2.       Market Revenue and Forecast, by Infection Type (2016-2027)

10.1.5.3.       Market Revenue and Forecast, by End User (2016-2027)

10.2.          Europe

10.2.1.  Market Revenue and Forecast, by Product & Service (2016-2027)

10.2.2.  Market Revenue and Forecast, by Infection Type (2016-2027)

10.2.3.  Market Revenue and Forecast, by End User (2016-2027)

10.2.4.  UK

10.2.4.1.       Market Revenue and Forecast, by Product & Service (2016-2027)

10.2.4.2.       Market Revenue and Forecast, by Infection Type (2016-2027)

10.2.4.3.       Market Revenue and Forecast, by End User (2016-2027)

10.2.5.  Germany

10.2.5.1.       Market Revenue and Forecast, by Product & Service (2016-2027)

10.2.5.2.       Market Revenue and Forecast, by Infection Type (2016-2027)

10.2.5.3.       Market Revenue and Forecast, by End User (2016-2027)

10.2.6.  France

10.2.6.1.       Market Revenue and Forecast, by Product & Service (2016-2027)

10.2.6.2.       Market Revenue and Forecast, by Infection Type (2016-2027)

10.2.6.3.       Market Revenue and Forecast, by End User (2016-2027)

10.2.7.  Rest of Europe

10.2.7.1.       Market Revenue and Forecast, by Product & Service (2016-2027)

10.2.7.2.       Market Revenue and Forecast, by Infection Type (2016-2027)

10.2.7.3.       Market Revenue and Forecast, by End User (2016-2027)

10.3.          APAC

10.3.1.  Market Revenue and Forecast, by Product & Service (2016-2027)

10.3.2.  Market Revenue and Forecast, by Infection Type (2016-2027)

10.3.3.  Market Revenue and Forecast, by End User (2016-2027)

10.3.4.  India

10.3.4.1.       Market Revenue and Forecast, by Product & Service (2016-2027)

10.3.4.2.       Market Revenue and Forecast, by Infection Type (2016-2027)

10.3.4.3.       Market Revenue and Forecast, by End User (2016-2027)

10.3.5.  China

10.3.5.1.       Market Revenue and Forecast, by Product & Service (2016-2027)

10.3.5.2.       Market Revenue and Forecast, by Infection Type (2016-2027)

10.3.5.3.       Market Revenue and Forecast, by End User (2016-2027)

10.3.6.  Japan

10.3.6.1.       Market Revenue and Forecast, by Product & Service (2016-2027)

10.3.6.2.       Market Revenue and Forecast, by Infection Type (2016-2027)

10.3.6.3.       Market Revenue and Forecast, by End User (2016-2027)

10.3.7.  Rest of APAC

10.3.7.1.       Market Revenue and Forecast, by Product & Service (2016-2027)

10.3.7.2.       Market Revenue and Forecast, by Infection Type (2016-2027)

10.3.7.3.       Market Revenue and Forecast, by End User (2016-2027)

10.4.          MEA

10.4.1.  Market Revenue and Forecast, by Product & Service (2016-2027)

10.4.2.  Market Revenue and Forecast, by Infection Type (2016-2027)

10.4.3.  Market Revenue and Forecast, by End User (2016-2027)

10.4.4.  GCC

10.4.4.1.       Market Revenue and Forecast, by Product & Service (2016-2027)

10.4.4.2.       Market Revenue and Forecast, by Infection Type (2016-2027)

10.4.4.3.       Market Revenue and Forecast, by End User (2016-2027)

10.4.5.  North Africa

10.4.5.1.       Market Revenue and Forecast, by Product & Service (2016-2027)

10.4.5.2.       Market Revenue and Forecast, by Infection Type (2016-2027)

10.4.5.3.       Market Revenue and Forecast, by End User (2016-2027)

10.4.6.  South Africa

10.4.6.1.       Market Revenue and Forecast, by Product & Service (2016-2027)

10.4.6.2.       Market Revenue and Forecast, by Infection Type (2016-2027)

10.4.6.3.       Market Revenue and Forecast, by End User (2016-2027)

10.4.7.  Rest of MEA

10.4.7.1.       Market Revenue and Forecast, by Product & Service (2016-2027)

10.4.7.2.       Market Revenue and Forecast, by Infection Type (2016-2027)

10.4.7.3.       Market Revenue and Forecast, by End User (2016-2027)

10.5.          Latin America

10.5.1.  Market Revenue and Forecast, by Product & Service (2016-2027)

10.5.2.  Market Revenue and Forecast, by Infection Type (2016-2027)

10.5.3.  Market Revenue and Forecast, by End User (2016-2027)

10.5.4.  Brazil

10.5.4.1.       Market Revenue and Forecast, by Product & Service (2016-2027)

10.5.4.2.       Market Revenue and Forecast, by Infection Type (2016-2027)

10.5.4.3.       Market Revenue and Forecast, by End User (2016-2027)

10.5.5.  Rest of LATAM

10.5.5.1.       Market Revenue and Forecast, by Product & Service (2016-2027)

10.5.5.2.       Market Revenue and Forecast, by Infection Type (2016-2027)

10.5.5.3.       Market Revenue and Forecast, by End User (2016-2027)

Chapter 11.   Company Profiles

11.1.                 3M Company

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.                 Belimed AG

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.                 Ecolab Inc

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.                 Fortive (Advanced Sterilization Products)

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.                 Getinge AB

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.                 Matachana Group

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.                 Miele Group

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.                 MMM Group

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.                 Sotera Health LLC

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

11.10.              Steris Plc.

11.10.1.                   Company Overview

11.10.2.                   Product Offerings

11.10.3.                   Financial Performance

11.10.4.                   Recent Initiatives

Chapter 12.   Research Methodology

12.1.                 Primary Research

12.2.                 Secondary Research

12.3.                 Assumptions

Chapter 13.   Appendix

13.1.                 About Us

13.2.                 Glossary of Terms